Modified ross procedure to prevent autograft dilatation

Ross M. Ungerleider; Yoshio Ootaki; Irving Shen; Karl F. Welke

doi:10.1016/j.athoracsur.2009.09.078

Modified ross procedure to prevent autograft dilatation

Ross M. Ungerleider, Yoshio Ootaki, Irving Shen, Karl F. Welke

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

The most prominent, long-term complication after the Ross procedure is autograft dilatation that can present within 1 to 2 years after the Ross operation. We describe a modified Ross procedure in which the autograft is completely encased in a Dacron graft (Hemashield; Maquet Cardiovascular, Wayne, NJ) prior to implantation. We have performed 30 modified Ross procedures since October 2004. There has been no mortality, and at follow-up none of the patients showed autograft dilatation. This article describes our current technique, which we believe is consistently reproducible and may be especially applicable to adults who are at risk for autograft dilatation after the Ross procedure.

Original language	English (US)
Pages (from-to)	1035-1037
Number of pages	3
Journal	Annals of Thoracic Surgery
Volume	90
Issue number	3
DOIs	https://doi.org/10.1016/j.athoracsur.2009.09.078
State	Published - Sep 2010
Externally published	Yes

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.athoracsur.2009.09.078

Fingerprint Dive into the research topics of 'Modified ross procedure to prevent autograft dilatation'. Together they form a unique fingerprint.

Cite this

@article{5a9d7d4975a14375ad0138f04e344fdd,

title = "Modified ross procedure to prevent autograft dilatation",

abstract = "The most prominent, long-term complication after the Ross procedure is autograft dilatation that can present within 1 to 2 years after the Ross operation. We describe a modified Ross procedure in which the autograft is completely encased in a Dacron graft (Hemashield; Maquet Cardiovascular, Wayne, NJ) prior to implantation. We have performed 30 modified Ross procedures since October 2004. There has been no mortality, and at follow-up none of the patients showed autograft dilatation. This article describes our current technique, which we believe is consistently reproducible and may be especially applicable to adults who are at risk for autograft dilatation after the Ross procedure.",

author = "Ungerleider, {Ross M.} and Yoshio Ootaki and Irving Shen and Welke, {Karl F.}",

year = "2010",

month = sep,

doi = "10.1016/j.athoracsur.2009.09.078",

language = "English (US)",

volume = "90",

pages = "1035--1037",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "3",

}

TY - JOUR

T1 - Modified ross procedure to prevent autograft dilatation

AU - Ungerleider, Ross M.

AU - Ootaki, Yoshio

AU - Shen, Irving

AU - Welke, Karl F.

PY - 2010/9

Y1 - 2010/9

N2 - The most prominent, long-term complication after the Ross procedure is autograft dilatation that can present within 1 to 2 years after the Ross operation. We describe a modified Ross procedure in which the autograft is completely encased in a Dacron graft (Hemashield; Maquet Cardiovascular, Wayne, NJ) prior to implantation. We have performed 30 modified Ross procedures since October 2004. There has been no mortality, and at follow-up none of the patients showed autograft dilatation. This article describes our current technique, which we believe is consistently reproducible and may be especially applicable to adults who are at risk for autograft dilatation after the Ross procedure.

AB - The most prominent, long-term complication after the Ross procedure is autograft dilatation that can present within 1 to 2 years after the Ross operation. We describe a modified Ross procedure in which the autograft is completely encased in a Dacron graft (Hemashield; Maquet Cardiovascular, Wayne, NJ) prior to implantation. We have performed 30 modified Ross procedures since October 2004. There has been no mortality, and at follow-up none of the patients showed autograft dilatation. This article describes our current technique, which we believe is consistently reproducible and may be especially applicable to adults who are at risk for autograft dilatation after the Ross procedure.

UR - http://www.scopus.com/inward/record.url?scp=77956133127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956133127&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2009.09.078

DO - 10.1016/j.athoracsur.2009.09.078

M3 - Article

C2 - 20732551

AN - SCOPUS:77956133127

VL - 90

SP - 1035

EP - 1037

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -

Modified ross procedure to prevent autograft dilatation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this